CHEMOTHERAPY OF LEISHMANIA WITH OLIQODEOXYNUCLEOTIDE PROBES

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$563,537.00
Award Year:
1990
Program:
SBIR
Phase:
Phase II
Contract:
n/a
Agency Tracking Number:
8864
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Micro-probe Corp.
1725 - 220th St Se/#104, Bothell, WA, 98021
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Dr Rich B Meyer Jr
(206) 485-8566
Business Contact:
() -
Research Institution:
n/a
Abstract
WE WILL INVESTIGATE THE ABILITY OF OLIGODEOXYNUCLEOTIDES COMPLEMENTARY TO THE SPLICED LEADER SEQUENCE OF LEISHMANIA ENRIETTII TUBULIN MRNA'S TO INHIT TRANSLATION AND TO KILL THE CELLS IN CULTURE. VARIOUS CHEMICAL MODIFICATIONS WILL BE MADE TO ENHANCE THE EFFECT OF THE OLIGOS. SUCCESSFUL AGENTS MAY BE VALUABLE, SELECTIVE CHEMOTHERAPEUTIC AGENTS AGAINST OTHER LEISHMANIA SPECIES IF MAD COMPLEMENTARY TO MRNA LEADERS FROM THOSE SPECIES.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government